Global Thyroid Functioning Tests Market, 2021

News provided by

Research and Markets

06 Oct, 2017, 17:15 GMT

DUBLIN, October 6, 2017 /PRNewswire/ --

The "Global Thyroid Functioning Tests Market 2017-2021" report has been added to Research and Markets' offering.

The global thyroid functioning tests market to grow at a CAGR of 4.60% during the period 2017-2021.

Global Thyroid Functioning Tests Market 2017-2021, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

One trend in the market is focus on partnerships and acquisitions for product development. Manufacturers are focusing on partnerships and acquisitions for product development to become leaders. For instance, in 2016, bioMrieux acquired Hyglos, which has expertise in developing recombinant proteins for detecting endotoxins.

According to the report, one driver in the market is rapid increase in older adult population. The older adult population is increasing worldwide. Almost every nation in the world is witnessing rapid rise in aging people. Currently, one of the most significant social transformations is the growth of aging population which is affecting nearly all sectors of society, including labor and financial markets as well as family structures and intergenerational ties. However, increase in older adult people does not necessarily imply the improvement in health. This rise brings several public health challenges, as with the increasing age, the immunity reduces significantly.

Further, the report states that one challenge in the market is varying normal range for thyroid function test. Most conventional physicians use thyroid function test to diagnose thyroid disorder and prescribe suitable medications, among which TSH test is the most common test. However, this test often produce misleading false result, as levels of hormones vary in various circumstances. For instance, in Hashimoto's disease, the levels of thyroid in individuals often fluctuate. Therefore, the need for setting up a standard normal range becomes important.

Key vendors

  • Abbott
  • bioMrieux
  • Danaher
  • DiaSorin
  • Siemens Healthineers

Other prominent vendors

  • Ameritek USA
  • Autobio Diagnostics
  • F. Hoffmann-La Roche
  • GeTein BioMedical
  • IBL-America
  • Sigma-Aldrich
  • Teco Diagnostics
  • Thermo Fisher Scientific

Key Topics Covered:

Part 01: Executive Summary

Part 02: Scope Of The Report

Part 03: Research Methodology

Part 04: Introduction

Part 05: Market Landscape

Part 06: Market Segmentation By Product

Part 07: Market Segmentation By End-User

Part 08: Geographical Segmentation

Part 09: Decision Framework

Part 10: Drivers And Challenges

Part 11: Market Trends

Part 12: Vendor Landscape

Part 13: Key Vendor Analysis

Part 14: Appendix

For more information about this report visit https://www.researchandmarkets.com/research/27bwmx/global_thyroid

Media Contact:

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Related Links

http://www.researchandmarkets.com